tradingkey.logo
tradingkey.logo
Search

Alnylam Pharmaceuticals Inc

ALNY
Add to Watchlist
205.420USD
-81.200-28.33%
Close 07-29 16:00ETQuotes delayed by 15 min
27.19BMarket Cap
50.28P/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-29
Previous score
10.00
Change
0
The current institutional shareholding score of Alnylam Pharmaceuticals Inc is 10.00, ranking 1 out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 100.11%, representing a quarter-over-quarter decrease of 1.92%. The largest institutional shareholder is ETHSX, holding a total of 444.37K shares, representing 0.30% of shares outstanding, with 3388.37% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
Capital World Investors
16.30M
-0.81%
Fidelity Management & Research Company LLC
15.08M
-5.17%
BlackRock Institutional Trust Company, N.A.
7.04M
+6.89%
Capital Research Global Investors
6.78M
-6.14%
JP Morgan Asset Management
4.00M
+3.38%
State Street Investment Management (US)
3.23M
+4.79%
Invesco Capital Management (QQQ Trust)
2.81M
-2.39%
Geode Capital Management, L.L.C.
2.65M
+6.06%
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.